IRIS
MARTINELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 440
EU - Europa 249
AS - Asia 139
OC - Oceania 2
AF - Africa 1
Totale 831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 437
IE - Irlanda 169
CN - Cina 98
FI - Finlandia 27
SG - Singapore 24
IT - Italia 20
DE - Germania 19
TR - Turchia 4
AT - Austria 3
IN - India 3
JP - Giappone 3
AU - Australia 2
BE - Belgio 2
GB - Regno Unito 2
IL - Israele 2
MX - Messico 2
NL - Olanda 2
UA - Ucraina 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
TH - Thailandia 1
TM - Turkmenistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 831
Salva come PNG Salva come JPEG
Città #
Dublin 169
Chandler 128
Boardman 36
Ashburn 33
Helsinki 27
New York 22
Lawrence 21
Princeton 21
Medford 20
Nanjing 20
Shanghai 18
Singapore 13
Shenyang 10
Beijing 9
Nanchang 9
Wilmington 9
Los Angeles 8
Changsha 6
Munich 5
Cagliari 4
Chicago 4
Hebei 4
Istanbul 4
Norwalk 4
Pavia 4
Jiaxing 3
Kunming 3
Redwood City 3
Rome 3
Seattle 3
Tianjin 3
Tokyo 3
Washington 3
Woodbridge 3
Anzio 2
Brisbane 2
Brussels 2
Fairfield 2
Guangzhou 2
Hangzhou 2
Jacksonville 2
Puebla City 2
Shenzhen 2
Verona 2
Amsterdam 1
Ann Arbor 1
Ashgabat 1
Athens 1
Atlanta 1
Bangkok 1
Barcelona 1
Bhubaneswar 1
Bishkek 1
Brescia 1
Brno 1
Centurion 1
Como 1
Dallas 1
Germantown 1
Haifa 1
Houston 1
Kurnool 1
London 1
Portland 1
Pune 1
Santa Clara 1
South Shields 1
Taizhou 1
Tel Aviv 1
Toronto 1
Vienna 1
Vientiane 1
Wuhan 1
Totale 684
Salva come PNG Salva come JPEG
Nome #
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 56
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 48
Functional and structural MRI signature of the induced migraine attack 47
A machine learning approach for the differential diagnosis of Alzheimer and vascular dementia fed by MRI selected features. 46
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 45
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm 44
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences 42
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 41
Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial 41
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 38
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults 37
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 37
Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study 36
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults 35
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study 34
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 32
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 32
Migraine neuroscience: from experimental models to target therapy 31
Chronic migraine and Botulinum Toxin Type A: Where do paths cross? 27
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 26
Lasmiditan: an additional therapeutic option for the acute treatment of migraine 26
Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study 23
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine 21
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 10
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 5
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 3
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 2
Totale 865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 1 0 6 4
2020/202129 2 0 0 3 1 11 1 8 2 1 0 0
2021/202271 0 1 1 0 0 0 0 10 3 0 9 47
2022/2023375 36 36 1 32 28 28 1 14 180 6 11 2
2023/2024199 34 20 8 17 19 38 4 20 4 10 6 19
2024/2025104 22 33 21 9 19 0 0 0 0 0 0 0
Totale 865